Psykey(OTC) CEOS

Market Cap$1.41M

Since IPO (2006)-100%

5 Year-94%

1 Year-44%

1 Month-36%

$0.00

+0.00%

+0.00Today

Psykey last closing stock price
Metric	Price	Date
Last close	USD 0.00	2026-08-31

Psykey stock price return by period
Period	Price return	Price at period start	Period start date
1 week	-22.01%	USD 0.01	2026-08-21
1 month	-36.17%	USD 0.01	2026-07-31
3 month	-31.79%	USD 0.01	2026-06-02
Year to date	+53.06%	USD 0.00	2025-12-31
1 year	-43.75%	USD 0.01	2025-08-29
3 year	-74.14%	USD 0.02	2023-09-01
5 year	-94.38%	USD 0.08	2021-09-01
Since inception	-99.94%	USD 7.63	2006-02-14

Psykey Financials at a Glance

Market Cap

$1.41M

Revenue (TTM)

$2.25M

Net Income (TTM)

-$1.48M

EPS (TTM)

$0.00

P/E Ratio

-1.12

Dividend

$0.00

Beta (Volatility)

0.14 (Low)

Dividend

$0.00

Beta (Volatility)

0.14 (Low)

Price

$0.00

Volume

28,000

Open

$0.00

Price

$0.00

Volume

28,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

Estimated Earnings Date

Aug 18, 2025

Dividend

$0.00

Beta (Volatility)

0.14 (Low)

Price

$0.00

Volume

28,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

Estimated Earnings Date

Aug 18, 2025

CEOS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Psykey

CeCors, Inc. is a healthcare company focused on acquiring and developing businesses that serve military veterans. The company operates through two main segments: PsyKey, which sells consumer goods, and VETCOMM, which provides educational resources and services.

Products and Services

Consumer goods, primarily coffee products through the PsyKey segment
Recurring services including education and resources for veterans via VETCOMM
Focus on enhancing the quality of life for military veterans

Growth Outlook

Recent quarterly revenue of $1,324,840 indicates strong sales growth
Gross profit margin of 99.88% reflects efficient cost management
Positive cash flow from operating activities of $505,318 in Q2 2024

Financial Highlights

Trailing twelve months (TTM) P/E ratio of 0.60 suggests potential undervaluation
Current ratio of 1.77 indicates good short-term financial health
Net income of -$409,901 in Q1 2026 shows ongoing investment in growth

AI Generated • Aug 15, 2026

Industry

Health Care Technology

Sector

Health Care

Employees

125

CEO

Michael Maher

Website

www.cecorsinc.com

Headquarters

Toronto, ON M9W1E8, CA

CEOS Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

733.40%

Return on Capital

-104.63%

Return on Assets

85.50%

Earnings Yield

-89.29%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.41M

Shares Outstanding

313.08M

Volume

28.00K

Avg. Volume

133.18K

Financials (TTM)

Gross Profit

$2.24M

Operating Income

-$833.72K

EBITDA

-$1.33M

Operating Cash Flow

$501.10K

Capital Expenditure

-$121.99K

Free Cash Flow

$379.11K

Cash & ST Invst.

$2.57M

Total Debt

$0.00

Psykey Performance Analysis

Psykey annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	USD 19,316	N/A
2023	2023-12-31	USD 419,299	2070.7%
2024	2024-12-31	USD 1,827	-99.6%
2025	2025-12-31	USD 0	N/A

Psykey sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2023-12-31	103.1%
Q1	2024-03-31	188.0%
Q2	2024-06-30	93.2%
Q1	2026-03-31	N/A

Psykey annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	USD -0.00	100.0%
2023	2023-12-31	USD -0.00	185.7%
2024	2024-12-31	USD -0.00	-75.0%
2025	2025-12-31	USD 0.01	N/A

Psykey sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2023-12-31	-187.5%
Q1	2024-03-31	69.6%
Q2	2024-06-30	57.1%
Q1	2026-03-31	N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$1.41M

N/A

Market Cap/Employee

$234.82K

N/A

Employees

N/A

Net Income

-$409.90K

-54.1%

EBITDA

-$292.48K

-12.5%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$2.57M

+2632.5%

Total Debt

$0.00

-100.0%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

-100.0%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$0.00

-100.0%

Return on Assets

85.50%

N/A

Return on Invested Capital

-1.05%

N/A

Free Cash Flow

-$427.18K

-1310.9%

Operating Cash Flow

-$427.18K

-1269.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

HDVYHealth Discovery Corporation

HDVYHealth Discovery Corporation$0.00+0.00%

NNBPNanobac Pharmaceuticals, Incorporated

NNBPNanobac Pharmaceuticals, Incorporated$0.00+0.00%

HADVHealth Advance Inc.

HADVHealth Advance Inc.$0.00-50.00%

RBIIRising Biosciences, Inc.

RBIIRising Biosciences, Inc.$0.00+0.00%

ISOLFIsodiol International Inc.

ISOLFIsodiol International Inc.$0.00+0.00%

OWCPOWC Pharmaceutical Research Corp.

OWCPOWC Pharmaceutical Research Corp.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

PCGPG&E

PCGPG&E$13.27-0.20%

NVDANvidia

NVDANvidia$220.78+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.97+0.11%

CNHCNH Industrial

CNHCNH Industrial$11.83+0.01%

NUNu Holdings

NUNu Holdings$14.55+0.02%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.63+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.43-0.02%

Questions About CEOS

What is the current price of Psykey?

Psykey is trading at $0.00 per share.

What is the 52-week range for Psykey?

Over the past 52 weeks, Psykey has traded between $0.00 and $0.01.

How much debt does Psykey have?

As of the most recent reporting period, Psykey reported total debt of $0.00.

How much cash does Psykey have on hand?

Psykey reported $2.57M in cash and cash equivalents in its most recent financial results.

What is Psykey’s dividend yield?

Psykey does not currently have a dividend yield.

Psykey(OTC) CEOS

Psykey Financials at a Glance

CEOS News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Psykey

CEOS Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Psykey Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CEOS

What is the current price of Psykey?

What is the 52-week range for Psykey?

How much debt does Psykey have?

How much cash does Psykey have on hand?

What is Psykey’s dividend yield?

Premium Investing Services